{
  "id": [
    "32573433"
  ],
  "source": [
    "MED"
  ],
  "pmid": [
    "32573433"
  ],
  "pmcid": [
    "PMC7311167"
  ],
  "fullTextIdList": [
    {
      "fullTextId": [
        "PMC7311167"
      ]
    }
  ],
  "doi": [
    "10.7554/elife.57877"
  ],
  "title": [
    "Antibodies to SARS-CoV-2 and their potential for therapeutic passive immunization."
  ],
  "authorString": [
    "Klasse PJ, Moore JP."
  ],
  "authorList": [
    {
      "author": [
        {
          "fullName": [
            "Klasse PJ"
          ],
          "firstName": [
            "P J"
          ],
          "lastName": [
            "Klasse"
          ],
          "initials": [
            "PJ"
          ],
          "authorId": [
            {
              "_": "0000-0001-8222-278X",
              "$": {
                "type": "ORCID"
              }
            }
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Department of Microbiology and Immunology, Weill Cornell Medicine, New York, United States."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Moore JP"
          ],
          "firstName": [
            "John P"
          ],
          "lastName": [
            "Moore"
          ],
          "initials": [
            "JP"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Department of Microbiology and Immunology, Weill Cornell Medicine, New York, United States."
              ]
            }
          ]
        }
      ]
    }
  ],
  "authorIdList": [
    {
      "authorId": [
        {
          "_": "0000-0001-8222-278X",
          "$": {
            "type": "ORCID"
          }
        }
      ]
    }
  ],
  "dataLinksTagsList": [
    {
      "dataLinkstag": [
        "altmetrics"
      ]
    }
  ],
  "journalInfo": [
    {
      "volume": [
        "9"
      ],
      "journalIssueId": [
        "2961129"
      ],
      "dateOfPublication": [
        "2020 Jun"
      ],
      "monthOfPublication": [
        "6"
      ],
      "yearOfPublication": [
        "2020"
      ],
      "printPublicationDate": [
        "2020-06-01"
      ],
      "journal": [
        {
          "title": [
            "eLife"
          ],
          "ISOAbbreviation": [
            "Elife"
          ],
          "medlineAbbreviation": [
            "Elife"
          ],
          "NLMid": [
            "101579614"
          ],
          "ISSN": [
            "2050-084X"
          ],
          "ESSN": [
            "2050-084X"
          ]
        }
      ]
    }
  ],
  "pubYear": [
    "2020"
  ],
  "abstractText": [
    "We review aspects of the antibody response to SARS-CoV-2, the causative agent of the COVID-19 pandemic. The topics we cover are relevant to immunotherapy with plasma from recovered patients, monoclonal antibodies against the viral S-protein, and soluble forms of the receptor for the virus, angiotensin converting enzyme 2. The development of vaccines against SARS-CoV-2, an essential public health tool, will also be informed by an understanding of the antibody response in infected patients. Although virus-neutralizing antibodies are likely to protect, antibodies could potentially trigger immunopathogenic events in SARS-CoV-2-infected patients or enhance infection. An awareness of these possibilities may benefit clinicians and the developers of antibody-based therapies and vaccines."
  ],
  "affiliation": [
    "Department of Microbiology and Immunology, Weill Cornell Medicine, New York, United States."
  ],
  "publicationStatus": [
    "epublish"
  ],
  "language": [
    "eng"
  ],
  "pubModel": [
    "Electronic"
  ],
  "pubTypeList": [
    {
      "pubType": [
        "review-article",
        "Review",
        "Journal Article",
        "Research Support, N.I.H., Extramural"
      ]
    }
  ],
  "grantsList": [
    {
      "grant": [
        {
          "grantId": [
            "R01 AI036082"
          ],
          "agency": [
            "NIAID NIH HHS"
          ],
          "acronym": [
            "AI"
          ],
          "orderIn": [
            "0"
          ]
        },
        {
          "grantId": [
            "P01 AI110657"
          ],
          "agency": [
            "NIH HHS"
          ],
          "acronym": [
            "NH"
          ],
          "orderIn": [
            "0"
          ]
        },
        {
          "grantId": [
            "P01 AI110657"
          ],
          "agency": [
            "NIAID NIH HHS"
          ],
          "acronym": [
            "AI"
          ],
          "orderIn": [
            "0"
          ]
        },
        {
          "grantId": [
            "R01 AI36082"
          ],
          "agency": [
            "NIH HHS"
          ],
          "acronym": [
            "NH"
          ],
          "orderIn": [
            "0"
          ]
        },
        {
          "grantId": [
            "OPP1132237"
          ],
          "agency": [
            "Bill and Melinda Gates Foundation"
          ],
          "orderIn": [
            "0"
          ]
        },
        {
          "grantId": [
            "INV-002022"
          ],
          "agency": [
            "Bill and Melinda Gates Foundation"
          ],
          "orderIn": [
            "0"
          ]
        }
      ]
    }
  ],
  "meshHeadingList": [
    {
      "meshHeading": [
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Humans"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "SARS Virus"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "IM"
                  ],
                  "qualifierName": [
                    "immunology"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Pneumonia, Viral"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "IM"
                  ],
                  "qualifierName": [
                    "immunology"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                },
                {
                  "abbreviation": [
                    "TH"
                  ],
                  "qualifierName": [
                    "therapy"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Coronavirus Infections"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "IM"
                  ],
                  "qualifierName": [
                    "immunology"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                },
                {
                  "abbreviation": [
                    "TH"
                  ],
                  "qualifierName": [
                    "therapy"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Antibodies, Monoclonal"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Antibodies, Viral"
          ]
        },
        {
          "majorTopic_YN": [
            "Y"
          ],
          "descriptorName": [
            "Immunization, Passive"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Pandemics"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Spike Glycoprotein, Coronavirus"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "CH"
                  ],
                  "qualifierName": [
                    "chemistry"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Betacoronavirus"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "IM"
                  ],
                  "qualifierName": [
                    "immunology"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Broadly Neutralizing Antibodies"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "IM"
                  ],
                  "qualifierName": [
                    "immunology"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        }
      ]
    }
  ],
  "keywordList": [
    {
      "keyword": [
        "Antibodies",
        "Plasma",
        "Microbiology",
        "Vaccine",
        "Therapy",
        "Infectious disease",
        "Covid-19",
        "Sars-cov-2"
      ]
    }
  ],
  "chemicalList": [
    {
      "chemical": [
        {
          "name": [
            "Antibodies, Viral"
          ],
          "registryNumber": [
            "0"
          ]
        },
        {
          "name": [
            "Antibodies, Monoclonal"
          ],
          "registryNumber": [
            "0"
          ]
        },
        {
          "name": [
            "Spike Glycoprotein, Coronavirus"
          ],
          "registryNumber": [
            "0"
          ]
        },
        {
          "name": [
            "Broadly Neutralizing Antibodies"
          ],
          "registryNumber": [
            "0"
          ]
        }
      ]
    }
  ],
  "subsetList": [
    {
      "subset": [
        {
          "code": [
            "IM"
          ],
          "name": [
            "Index Medicus"
          ]
        }
      ]
    }
  ],
  "fullTextUrlList": [
    {
      "fullTextUrl": [
        {
          "availability": [
            "Subscription required"
          ],
          "availabilityCode": [
            "S"
          ],
          "documentStyle": [
            "doi"
          ],
          "site": [
            "DOI"
          ],
          "url": [
            "https://doi.org/10.7554/eLife.57877"
          ]
        },
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "html"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "https://europepmc.org/articles/PMC7311167"
          ]
        },
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "pdf"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "https://europepmc.org/articles/PMC7311167?pdf=render"
          ]
        }
      ]
    }
  ],
  "commentCorrectionList": [
    {
      "commentCorrection": [
        {
          "id": [
            "PPR152704"
          ],
          "source": [
            "PPR"
          ],
          "type": [
            "Preprint in"
          ],
          "note": [
            "CrossRef Pre-print loader"
          ],
          "orderIn": [
            "10002"
          ]
        }
      ]
    }
  ],
  "isOpenAccess": [
    "Y"
  ],
  "inEPMC": [
    "Y"
  ],
  "inPMC": [
    "N"
  ],
  "hasPDF": [
    "Y"
  ],
  "hasBook": [
    "N"
  ],
  "hasSuppl": [
    "N"
  ],
  "citedByCount": [
    "0"
  ],
  "hasData": [
    "N"
  ],
  "hasReferences": [
    "Y"
  ],
  "hasTextMinedTerms": [
    "Y"
  ],
  "hasDbCrossReferences": [
    "N"
  ],
  "hasLabsLinks": [
    "Y"
  ],
  "license": [
    "cc by"
  ],
  "authMan": [
    "N"
  ],
  "epmcAuthMan": [
    "N"
  ],
  "nihAuthMan": [
    "N"
  ],
  "hasTMAccessionNumbers": [
    "N"
  ],
  "dateOfCompletion": [
    "2020-06-30"
  ],
  "dateOfCreation": [
    "2020-06-24"
  ],
  "firstIndexDate": [
    "2020-06-24"
  ],
  "fullTextReceivedDate": [
    "2020-06-26"
  ],
  "dateOfRevision": [
    "2020-06-30"
  ],
  "electronicPublicationDate": [
    "2020-06-23"
  ],
  "firstPublicationDate": [
    "2020-06-23"
  ]
}